Immunology
-
Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
This article has 15 authors:Reviewed by ScreenIT
-
Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and Variants of Concerns
This article has 15 authors:Reviewed by ScreenIT
-
A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
This article has 6 authors:Reviewed by ScreenIT
-
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
This article has 61 authors:Reviewed by ScreenIT
-
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
This article has 29 authors:Reviewed by ScreenIT
-
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
This article has 32 authors:Reviewed by ScreenIT
-
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
This article has 20 authors:Reviewed by ScreenIT
-
Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques
This article has 23 authors:Reviewed by ScreenIT
-
The vaccinia‐based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses
This article has 12 authors:Reviewed by ScreenIT
-
SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
This article has 11 authors:Reviewed by ScreenIT